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Background:  Previous studies claiming the relationship between thyroid dysfunction and poor prognosis of heart failure (HF) had a 
major limitation that they included patients with different etiology. With a cohort of idiopathic dilated cardiomyopathy (IDCM), we tested the 
hypothesis that thyroid status can independently influence the mortality of HF.
methods:  The original cohort consisted of 572 consecutive patients with IDCM, and 458 patients remained at the end of follow-up. The risk 
of mortality was evaluated based on fT3, TSH, and the whole thyroid function profile, respectively.
results:  The most frequent thyroid dysfunction was subclinical hypothyroidism (n=41), followed by subclinical hyperthyroidism (n=35), 
low-T3 syndrome (n=17), and hypothyroidism (n=12). Logistic analysis showed log-TSH and fT3 as independent predictors of exacerbated 
cardiac function (NYHA III-IV vs NYHA I-II). During the follow-up (17±8 months), 111 cumulative deaths occurred. Hypothyroidism was the 
strongest predictor of mortality (hazard ratio (HR), 4.189; 95%CI, 2.118-8.283), followed by low-T3 syndrome (HR, 3.147; 95%CI, 1.558-
6.355) and subclinical hypothyroidism (HR, 2.869; 95%CI, 1.817-4.532). Subclinical hyperthyroidism showed no significant impact.
conclusion:  We found clear association between thyroid dysfunction and an increased risk of mortality in IDCM. These results suggest 
that monitoring thyroid function in HF patients is necessary, and further studies on treatment is needed.
 
